A carregar...

Novel Agents for the Treatment of Type 2 Diabetes

In Brief Impaired insulin secretion, increased hepatic glucose production, and decreased peripheral glucose utilization are the core defects responsible for the development and progression of type 2 diabetes. However, the pathophysiology of this disease also includes adipocyte insulin resistance (in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Spectr
Main Authors: DeFronzo, Ralph A., Triplitt, Curtis L., Abdul-Ghani, Muhammad, Cersosimo, Eugenio
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522879/
https://ncbi.nlm.nih.gov/pubmed/26246766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaspect.27.2.100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!